Welcome to LookChem.com Sign In|Join Free

CAS

  • or

24188-74-7

Post Buying Request

24188-74-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

24188-74-7 Usage

Description

7-CHLORO-1-HYDROXYISOQUINOLINE is an organic compound with the molecular formula C9H7ClNO. It is a derivative of isoquinoline, which is a tricyclic aromatic alkaloid. 7-CHLORO-1-HYDROXYISOQUINOLINE is characterized by the presence of a chlorine atom at the 7th position and a hydroxyl group at the 1st position. It is known for its potential applications in the pharmaceutical and chemical industries due to its unique structural properties.

Uses

Used in Pharmaceutical Industry:
7-CHLORO-1-HYDROXYISOQUINOLINE is used as a reagent for the preparation of various compounds, including methoxyisoquinoline derivatives. It plays a crucial role in the synthesis of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor, which is utilized for the treatment of hepatitis C virus infection. This application highlights the compound's importance in the development of antiviral medications.
Used in Medicinal Chemistry Research:
7-CHLORO-1-HYDROXYISOQUINOLINE is employed as a key intermediate in the synthesis and pharmacological evaluation of a series of 1,2-dihydro-1-[(5-methyl-1-imidazol-4-yl)methyl]-2-oxopyridine 5-HT3 antagonists. These antagonists are significant in the field of medicinal chemistry, as they have the potential to be developed into new drugs for the treatment of various disorders related to the serotonin system, such as anxiety, depression, and gastrointestinal disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 24188-74-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,1,8 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 24188-74:
(7*2)+(6*4)+(5*1)+(4*8)+(3*8)+(2*7)+(1*4)=117
117 % 10 = 7
So 24188-74-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H6ClNO/c10-7-2-1-6-3-4-11-9(12)8(6)5-7/h1-5H,(H,11,12)

24188-74-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-chloro-2H-isoquinolin-1-one

1.2 Other means of identification

Product number -
Other names 7-Chlorisocarbostyril

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24188-74-7 SDS

24188-74-7Relevant articles and documents

The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection

Scola, Paul M.,Sun, Li-Qiang,Wang, Alan Xiangdong,Chen, Jie,Sin, Ny,Venables, Brian L.,Sit, Sing-Yuen,Chen, Yan,Cocuzza, Anthony,Bilder, Donna M.,D'Andrea, Stanley V.,Zheng, Barbara,Hewawasam, Piyasena,Tu, Yong,Friborg, Jacques,Falk, Paul,Hernandez, Dennis,Levine, Steven,Chen, Chaoqun,Yu, Fei,Sheaffer, Amy K.,Zhai, Guangzhi,Barry, Diana,Knipe, Jay O.,Han, Yong-Hae,Schartman, Richard,Donoso, Maria,Mosure, Kathy,Sinz, Michael W.,Zvyaga, Tatyana,Good, Andrew C.,Rajamani, Ramkumar,Kish, Kevin,Tredup, Jeffrey,Klei, Herbert E.,Gao, Qi,Mueller, Luciano,Colonno, Richard J.,Grasela, Dennis M.,Adams, Stephen P.,Loy, James,Levesque, Paul C.,Sun, Huabin,Shi, Hong,Sun, Lucy,Warner, William,Li, Danshi,Zhu, Jialong,Meanwell, Nicholas A.,McPhee, Fiona

, p. 1730 - 1752 (2014)

The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is currently in phase III clinical trials for the treatment of hepatitis C virus infection. The discovery of 24 was enabled by employing an isolated rabbit heart model to screen for the cardiovascular (CV) liabilities (changes to HR and SNRT) that were responsible for the discontinuation of an earlier lead from this chemical series, BMS-605339 (1), from clinical trials. The structure-activity relationships (SARs) developed with respect to CV effects established that small structural changes to the P2* subsite of the molecule had a significant impact on the CV profile of a given compound. The antiviral activity, preclincial PK profile, and toxicology studies in rat and dog supported clinical development of BMS-650032 (24).

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 00950; 00951, (2021/01/22)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

Process for Synthesizing Substituted Isoquinolines

-

Page/Page column 6, (2010/04/23)

The present disclosure generally relates to a process for synthesizing optionally substituted 1-chloro-4-methoxyisoquinolines. The present disclosure also relates to intermediates useful in this process.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24188-74-7